Miklas, Jason W.
Clark, Elisa http://orcid.org/0000-0003-4267-7215
Levy, Shiri
Detraux, Damien http://orcid.org/0000-0002-9704-2076
Leonard, Andrea
Beussman, Kevin
Showalter, Megan R.
Smith, Alec T.
Hofsteen, Peter
Yang, Xiulan
Macadangdang, Jesse
Manninen, Tuula
Raftery, Daniel http://orcid.org/0000-0003-2467-8118
Madan, Anup
Suomalainen, Anu http://orcid.org/0000-0003-4833-5195
Kim, Deok-Ho http://orcid.org/0000-0002-6989-6074
Murry, Charles E. http://orcid.org/0000-0003-3862-6773
Fiehn, Oliver http://orcid.org/0000-0002-6261-8928
Sniadecki, Nathan J. http://orcid.org/0000-0001-6960-4492
Wang, Yuliang
Ruohola-Baker, Hannele
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01GM097372, 1P01GM081619, R01HL135143)
Article History
Received: 26 September 2018
Accepted: 10 September 2019
First Online: 11 October 2019
Change Date: 8 May 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: N.J.S. is a co-founder, board member, and has equity in Stasys Medical Corporation. He is also a scientific advisor and has equity in Nanosurface Biomedical Inc. C.E.M. is a scientific founder and equity holder in Cytocardia. D.H.K. is a scientific founder and equity holder in NanoSurface Biomedical Inc. J.W.M was a paid consultant of Nanosurface Biomedical Inc. H.R.B. is a member of the Nanosurface Biomedical Inc. scientific advisory board.